[1]
Armstrong, A.W. , Park, S.H. , Patel, V. , Hogan, M. , Wang, W.-J. , Davidson, D. and Chirikov, V. 2023. Matching-adjusted indirect comparison (MAIC) of deucravacitinib versus adalimumab for the treatment of patients with moderate to severe plaque psoriasis over 2 years. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s112. DOI:https://doi.org/10.25251/skin.7.supp.112.